Robbins Geller Rudman & Dowd LLP Announces Pending Class Action Lawsuit in the Tivity Health Securities LitigationOctober 24, 2024 at 08:00 AM EDT
The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Tivity Health Securities Litigation:
UNITED STATES DISTRICT COURT
TO: ALL PERSONS WHO PURCHASED OR OTHERWISE ACQUIRED TIVITY HEALTH, INC. COMMON STOCK BETWEEN MARCH 8, 2019 AND FEBRUARY 19, 2020, INCLUSIVE YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the Middle District of Tennessee, that the lawsuit that is now pending in that Court under the caption Strougo v. Tivity Health, Inc., et al., Civil Action No. 3:20-cv-00165 (M.D. Tenn.) (the “Action”) against Tivity Health, Inc. (“Tivity Health”), Donato Tramuto, Adam C. Holland, and Dawn Zier, has been certified as a class action on behalf of the Class, except for certain persons and entities that are excluded from the Class by definition as set forth in the full printed Notice of Pendency of Class Action (“Notice”). IF YOU ARE A MEMBER OF THE CLASS, YOUR RIGHTS WILL BE AFFECTED BY THIS ACTION. A Postcard Notice is currently being mailed or emailed to known Class Members. If you have not yet received the Postcard Notice, or you wish to obtain a copy of the Notice, you may contact the Notice Administrator at:
Tivity Health Securities Litigation
Inquiries, other than requests for the Notice, may be made to Class Counsel:
Christopher M. Wood, Esq.
If you are a Class Member, you have the right to decide whether to remain a member of the Class. If you choose to remain a member of the Class, you do not need to do anything at this time other than to retain your documentation reflecting your transactions and holdings in Tivity Health common stock. You will automatically be included in the Class. If you are a Class Member and do not exclude yourself from the Class, you will be bound by the proceedings in this Action, including all past, present, and future orders and judgments of the Court, whether favorable or unfavorable. At this time there has been no monetary recovery, and there is no guarantee that one will be obtained in the future. If you ask to be excluded from the Class, you will not be bound by any order or judgment of this Court, and you will not be eligible to receive a share of any money which might be recovered for the benefit of the Class. To exclude yourself from the Class, you must submit a written request for exclusion postmarked no later than December 2, 2024, in accordance with the instructions set forth in the full printed Notice. Please note, if you decide to exclude yourself from the Class, you may be time-barred from asserting the claims covered by the Action by a statute of repose. Pursuant to Rule 23(e)(4) of the Federal Rules of Civil Procedure, it is within the Court’s discretion as to whether a second opportunity to request exclusion from the Class will be allowed if there is a settlement in the Action. Further information may be obtained by directing your inquiry in writing to the Notice Administrator or by visiting www.TivityHealthSecuritiesLitigation.com. Please Do Not Call or Write the Defendants or the Court with Questions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241024364767/en/ Contacts
Media:
More NewsView More
DoorDash’s Recent Stock Dip Equals 60% Upside ↗
Today 12:15 EST
Via MarketBeat
Tickers
DASH
Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026 ↗
Today 10:22 EST
Via MarketBeat
Tickers
WSM
Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact ↗
Today 10:17 EST
Via MarketBeat
Tickers
META
Via MarketBeat
Tickers
SBUX
MP Materials Stock Soared After Earnings—Here’s the Real Reason ↗
November 22, 2025
Via MarketBeat
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||